You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API lidocaine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing lidocaine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Par Pharmaceutical LIDOCAINE lidocaine 0603-1880 CARBOXYMETHYLCELLULOSE SODIUM
Par Pharmaceutical LIDOCAINE lidocaine 0603-1880 DIHYDROXYALUMINUM AMINOACETATE
Par Pharmaceutical LIDOCAINE lidocaine 0603-1880 EDETATE DISODIUM
Par Pharmaceutical LIDOCAINE lidocaine 0603-1880 GELATIN
Par Pharmaceutical LIDOCAINE lidocaine 0603-1880 GLYCERIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing lidocaine

Company Ingredient NDC Excipient
Fougera Pharmaceuticals Inc lidocaine 0168-0204 POLYETHYLENE GLYCOL 1450
Fougera Pharmaceuticals Inc lidocaine 0168-0204 POLYETHYLENE GLYCOL 300
Septodont Inc lidocaine 0362-0221 POLYETHYLENE GLYCOL 1450
Septodont Inc lidocaine 0362-0221 POLYETHYLENE GLYCOL 300
Mylan Pharmaceuticals Inc lidocaine 0378-9055 POLYISOBUTYLENE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for lidocaine

Excipient focus: ALUMINUM SILICATE

Excipient focus: ANHYDROUS CITRIC ACID

lidocaine drug variants containing ANHYDROUS CITRIC ACID

Company Ingredient NDC
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1232
HF Acquisition Co LLC DBA HealthFirst lidocaine hci 51662-1419
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1395
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epinephrine 51662-1503
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epinephrine 51662-1504
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BUTYLATED HYDROXYTOLUENE

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CARBOXYPOLYMETHYLENE

Excipient focus: CITRIC ACID ANHYDROUS

Excipient focus: CITRIC ACID MONOHYDRATE

lidocaine drug variants containing CITRIC ACID MONOHYDRATE

Company Ingredient NDC
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1505
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine 51662-1506
HF Acquisition Co LLC DBA HealthFirst lidocaine hci and epinephrine with epinephrine 51662-1412
HF Acquisition Co LLC DBA HealthFirst lidocaine hcl and epi 51662-1589
B Braun Medical Inc lidocaine hcl and epinephrine 0264-9378
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: DEXTROSE MONOHYDRATE

Excipient focus: DIETHYLENE GLYCOL MONOETHYL ETHER

Excipient focus: DIHYDROXYALUMINUM AMINOACETATE

Excipient focus: DIPROPYLENE GLYCOL

Excipient focus: EDETATE DISODIUM

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: ISOSTEARIC ACID

Excipient focus: KAOLIN

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: OLEIC ACID

Excipient focus: ORANGE

Excipient focus: PEG-50 HYDROGENATED CASTOR OIL

Excipient focus: PEG-54 HYDROGENATED CASTOR OIL

Excipient focus: PEG-55 HYDROGENATED CASTOR OIL

lidocaine drug variants containing PEG-55 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Actavis Pharma Inc lidocaine and prilocaine 0591-2070
DIRECT RX lidocaine and prilocaine 61919-443
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-825
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-826
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-828
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: PEG-60 HYDROGENATED CASTOR OIL

Excipient focus: PEPPERMINT OIL

Excipient focus: PETROLATUM

Excipient focus: PHOSPHORIC ACID

Excipient focus: POLOXAMER 188

Excipient focus: POLOXAMER 407

Excipient focus: POLYACRYLIC ACID

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1450

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYISOBUTYLENE

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

Excipient focus: POLYOXYL 60 HYDROGENATED CASTOR OIL

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM BISULFITE

Excipient focus: POTASSIUM METABISULFITE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

lidocaine drug variants containing SODIUM HYDROXIDE

Company Ingredient NDC
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-825
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-826
Sterling-knight PharmaceuticalsLLC lidocaine 2.5% and prilocaine 2.5% 69336-828
Amneal Pharmaceuticals of New York LLC lidocaine and prilocaine 0115-1468
E Fougera & Co a division of Fougera Pharmaceuticals Inc lidocaine and prilocaine 0168-0357
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM METABISULFITE

lidocaine drug variants containing SODIUM METABISULFITE

Company Ingredient NDC
B Braun Medical Inc lidocaine hcl and epinephrine 0264-9378
Henry Schein Inc lidocaine hydrochloride and epinephrine 0404-9886
Hospira Inc lidocaine hydrochloride and epinephrine 0409-1209
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-3321
A-S Medication Solutions lidocaine hydrochloride,epinephrine bitartrate 50090-6851
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM POLYACRYLATE

Excipient focus: SORBITAN MONOPALMITATE

Excipient focus: SORBITOL

Excipient focus: TARTARIC ACID

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: UREA

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group